Ebola Vaccine Passes First Human Safety Test
An AP newswire article, via MSNBC, reports that:
The first vaccine designed to prevent infection with the lethal Ebola virus has passed initial safety tests in people and has shown promising signs that it may indeed protect people from contracting the disease, government scientists reported Friday.
Just 21 people received the experimental vaccine in this early stage testing. Much more research is necessary to prove whether the vaccine will pan out, cautioned lead researcher Dr. Gary Nabel of the National Institutes of Health.
But the results are encouraging for U.S. scientists who worry not only that the horrific virus might be used as a terrorist weapon, but also note that natural outbreaks in Africa seem to be on the rise.